![]() ![]() According to LinkDoc’s prospectus, the domestic market size in 2019 was $4.1 billion, with a compound annual growth rate of 43.9% over the past five years, and it is expected to reach $215.4 billion in 2030. SEE ALSO: XPeng Announces Global Offering of 85 Million Shares at HK$165 Per ShareĬhina’s medical big data market is developing at a high speed. Since 2015, the company has provided nursing services for more than 3.5 million patients. ![]() The company’s platforms include digital nursing platform LinkCare, medical data management system LinkData and LinkSolutions. The company provides services for patient care and clinical research, especially in the field of oncology. Zhang Tianze, founder and CEO, also serves as the largest shareholder in the company, accounting for 17.3% of shares and 67.6% of voting rights following the IPO. The IPO will raise about $200 million and aims to increase the firm’s overall market value to roughly $1.5 billion.įounded in 2014, LinkDoc is a Beijing-based company that provides various data-driven and artificial intelligence-supported medical technology platforms. Its investors include Alibaba Health Information. Moreover, the deal’s underwriters hold an additional 1,623,750 over-allotment rights. LinkDoc, founded in 2014, provides cancer focused health-care services built on big data and artificial intelligence, its website shows. LinkDoc plans to sell 10,825,000 American depositary shares (ADS) in this IPO, with the issue price range to be set between $17.50 and $19.50 per share. The underwriters for the listing are Morgan Stanley, Bank of America Merrill Lynch, CICC, UP Fintech Holding and Snowball. listing by a Chinese firm on record, after Alibaba Group Holding Ltd.’s $25 billion blockbuster debut in 2014.LinkDoc Technology Limited, a Chinese medical technology company, updated its IPO application on July 6, planning to list on NASDAQ under the ticker symbol “LDOC”. this year, according to data compiled by Bloomberg. Its investors include Alibaba Health Information Technology Ltd., MBK Partners, New Enterprise Associates and Temasek Holdings Pte according to a preliminary filing.Ĭhinese companies have raised about $13 billion through first-time share sales in the U.S. LinkDoc, founded in 2014, provides cancer focused health-care services built on big data and artificial intelligence, its website shows. LinkDoc Technology Ltd., a Chinese medical data company, is seeking to raise money in a private fundraising, according to people familiar with the matter, after suspending plans for a July U.S. LinkDoc - LDOC US Health Care China Analysis Discussions Announcements News Insights Reports Relevant bullish LinkDoc 03:52 LinkDoc Technology IPO Valuation Analysis Our base case valuation of LinkDoc Technology suggests an implied market cap of 2.0 billion or 22. A representative for LinkDoc declined to comment. Reuters reported LinkDoc’s IPO halt earlier Thursday. The Company provides medical big data integration, medical images intelligent diagnosis. LinkDoc’s IPO delay also comes as regulators in Beijing are planning rule changes that would allow them to block a Chinese company from listing overseas even if the unit selling shares is incorporated outside China, closing a loophole long-used by the country’s technology giants, Bloomberg News reported this week. LinkDoc Technology Limited operates as a medical data solutions and oncology big data services provider. plunged after the government ordered the removal of the ride-hailing giant’s app from local app stores within days of its $4.4 billion U.S. ![]() were arranging the deal.Ĭhinese technology stocks suffered a rout after China signaled a new era of tighter oversight over cybersecurity. LinkDoc was slated to price the offering on Thursday, which could have raised as much as $211 million. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |